Genomic mutations and homologous recombination deficiency (HRD) score in Japanese patients with metastatic hormone-sensitive prostate cancer (mHSPC): The impact of intraductal carcinoma of the prostate (IDC-P).

Masashi Kato,Yushi Naito,Hideji Kawanishi,Toyonori Tsuzuki,Akiyuki Yamamoto,Shusuke Akamatsu

doi:10.1200/jco.2024.42.4_suppl.195

Genomic mutations and homologous recombination deficiency (HRD) score in Japanese patients with metastatic hormone-sensitive prostate cancer (mHSPC): The impact of intraductal carcinoma of the prostate (IDC-P).

Masashi Kato, Yushi Naito + Show 4 more

https://doi.org/10.1200/jco.2024.42.4_suppl.195

Copy DOI

Journal: Journal of Clinical Oncology

Publication Date: Feb 1, 2024

Affiliation: Nagoya University, Nagoya University Hospital, Aichi Medical University Hospital, Toyohashi Municipal Hospital

#Intraductal Carcinoma Of The Prostate #Metastatic Hormone-sensitive Prostate Cancer + Show 8 more

Abstract
Full-Text
Similar Papers

Abstract

Genomic mutations and homologous recombination deficiency (HRD) score in Japanese patients with metastatic hormone-sensitive prostate cancer (mHSPC): The impact of intraductal carcinoma of the prostate (IDC-P).

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Journal of Clinical Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.